Memantine in Patients with Moderate to Severe Alzheimer's Disease: Meta-Analyses Using Realistic Definitions of Response

Publisher： Karger

E-ISSN： 1421-9824|37|1-2|71-85

ISSN： 1420-8008

Source： Dementia and Geriatric Cognitive Disorders, Vol.37, Iss.1-2, 2013-10, pp. : 71-85

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Memantine in Moderate to Severe Alzheimer’s Disease: a Meta-Analysis of Randomised Clinical Trials

By  

Dementia and Geriatric Cognitive Disorders, Vol. 24, Iss. 1, 2007-05 ,pp. : 20-27

Karger

Access to resources Recommend Favorite

Specific Functional Effects of Memantine Treatment in Patients with Moderate to Severe Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 18, Iss. 2, 2004-08 ,pp. : 227-232

Karger

Access to resources Recommend Favorite

Memantine Therapy of Behavioral Symptoms in Community-Dwelling Patients with Moderate to Severe Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 27, Iss. 2, 2009-02 ,pp. : 164-172

Karger

Access to resources Recommend Favorite

Analysis of the Effect of Memantine in Reducing the Worsening of Clinical Symptoms in Patients with Moderate to Severe Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 24, Iss. 2, 2007-07 ,pp. : 138-145

Karger

Access to resources Recommend Favorite

Efficacy and Safety of Donepezil 23 mg versus Donepezil 10 mg for Moderate-to-Severe Alzheimer’s Disease: A Subgroup Analysis in Patients Already Taking or Not Taking Concomitant Memantine

By  

Dementia and Geriatric Cognitive Disorders, Vol. 33, Iss. 2-3, 2012-05 ,pp. : 164-173

Karger

Access to resources Recommend Favorite